Literature DB >> 7768397

Role of acid and duodenogastric reflux in esophageal mucosal injury: a review of animal and human studies.

M F Vaezi1, S Singh, J E Richter.   

Abstract

The role of acid and duodenogastric reflux (DGR) in the development of esophageal mucosal injury has been extensively investigated using both animal and human models. In this report, clinical and experimental data are reviewed. The mechanisms by which gastric and duodenal contents produce esophageal mucosal injury are also discussed. Acid and pepsin are unquestionably important in causing mucosal damage at low pH values in both animal and human models. Animal models suggest synergistic damaging potential for conjugated bile acids and HCI as well as that of unconjugated bile acids and trypsin in more neutral pH values. Human evidence for the involvement of bile and its constituents has been controversial; however, the advent of better technology to detect DGR is beginning to clarify the role of these constituents. The contribution of each methodology in clarifying the extent of involvement of DGR in esophageal mucosal injury is reviewed. Despite some conflicting results, preliminary human studies support the results from the animal data suggesting synergistic damaging effects for both bile and acid in esophageal mucosal injury. The implication of these studies in treating gastroesophageal reflux disease are discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7768397     DOI: 10.1016/0016-5085(95)90156-6

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  41 in total

1.  Proton pump inhibitors for Barrett's oesophagus.

Authors:  G Triadafilopoulos
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

Review 2.  Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.

Authors:  J A Jankowski; N A Wright; S J Meltzer; G Triadafilopoulos; K Geboes; A G Casson; D Kerr; L S Young
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

Review 3.  Surveillance in Barrett's oesophagus: a personal view.

Authors:  K K Basu; J S de Caestecker
Journal:  Postgrad Med J       Date:  2002-05       Impact factor: 2.401

4.  Jejunal pouch interposition with fundic-like plication after total gastrectomy.

Authors:  Takeyoshi Yumiba; Hisayoshi Kawahara; Kazuhiro Nishikawa; Toshirou Nishida; Yoshifumi Inoue; Toshinori Ito; Hikaru Matsuda
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

5.  Impedance-pH monitoring in proton pump inhibitor resistant patients: ready for clinical application?

Authors:  J P Galmiche
Journal:  Gut       Date:  2006-10       Impact factor: 23.059

Review 6.  Non-acid gastroesophageal reflux: documenting its relationship to symptoms using multichannel intraluminal impedance (MII).

Authors:  Donald O Castell; Inder Mainie; Radu Tutuian
Journal:  Trans Am Clin Climatol Assoc       Date:  2005

7.  Analysis of the protective biochemical and pathologic effects of aminoguanidine on an experimental aspiration pneumonitis model induced by bile acids.

Authors:  Rifat Karli; Hasan Alacam; Latif Duran; Omer Alici; Celal Kati; Arzu Karli; Ahmet Guzel
Journal:  Curr Ther Res Clin Exp       Date:  2012-12

8.  Esophageal visceral sensitivity to bile salts in patients with functional heartburn and in healthy control subjects.

Authors:  Ali Siddiqui; Sheila Rodriguez-Stanley; Sattar Zubaidi; Philip B Miner
Journal:  Dig Dis Sci       Date:  2005-01       Impact factor: 3.199

9.  Effect of proton pump inhibition on acid, weakly acid and weakly alkaline gastro-esophageal reflux in children.

Authors:  Helena Turk; Bruno Hauser; Jernej Brecelj; Yvan Vandenplas; Rok Orel
Journal:  World J Pediatr       Date:  2013-02-07       Impact factor: 2.764

10.  Primary duodenogastric reflux in children and adolescents.

Authors:  Dominique Hermans; Etienne-Marc Sokal; Jean-Marie Collard; Renato Romagnoli; Jean-Paul Buts
Journal:  Eur J Pediatr       Date:  2003-06-26       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.